Compare Sinar Eka Selaras Tbk. (ERAL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinar Eka Selaras Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinar Eka Selaras Tbk. trades at Rp284 (market cap 1.47T, 501.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Sinar Eka Selaras Tbk. is far larger — about 8.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sinar Eka Selaras Tbk. is more actively traded (501.8K versus 71K). Which is the better fit depends on your goals.
| ERAL | OBAT | |
|---|---|---|
Market Cap | 1.47T | 167.37B |
Volume | 501.8K | 71K |
Lot | 5.02K | 710 |
Turnover | 141.93M | 17.51M |
Average Price | 282.83 | 246.63 |
Value | 141.93M | 17.51M |
Indicative Equilibrium Price | 284 | 246 |
Indicative Equilibrium Volume | 10 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
